The $4 Generic List in 2025: An Audit of What Walmart, Kroger, and Publix Still Cover
When Walmart rolled out its $4 generic prescription program in 2006, critics predicted it would be a short-lived publicity stunt. Nearly twenty years later, the program — and the imitators it inspired — is still going strong, though most patients have no idea it exists. At RxPriceWatch, we believe that overlooking these lists means leaving real money on the table, so we decided to audit what the major programs actually cover heading into 2025.
Where the $4 List Came From
The original program launched in a handful of Florida stores and covered roughly 300 generic medications at $4 for a 30-day supply, or $10 for 90 days. Within two years, Target, Kroger, and regional grocers like Publix had followed with versions of their own. The lists were never designed as loss leaders on every drug — they were curated selections of high-volume generics where pharmacies could still turn a modest profit while driving foot traffic.
That curation is the key to understanding these programs today. They are marketing instruments, not entitlements, which means the contents shift without announcement.
What the Programs Look Like in 2025
Walmart continues to offer its $4/30-day and $10/90-day list, alongside a separate tier of discounted medications priced between $7.50 and $40. The core list remains heavy on chronic-disease workhorses: metformin, lisinopril, atorvastatin, amlodipine, and levothyroxine all still appear.
Kroger operates a similar structure through its Rx Savings Club, with a large tier of medications at reduced flat rates for members. The program covers many antibiotics, blood pressure medications, and mental health generics.
Publix offers a well-known free medication list — yes, free — covering certain antibiotics and chronic-use drugs like metformin and lisinopril in 14-day supplies, with limits on quantity. It is one of the most generous programs in the Southeast, and one of the least advertised.
What Has Quietly Disappeared
Here is where patients get burned. Lists shrink without notice. Medications that were $4 two years ago now sit in the standard-priced tier, and nobody at the counter will flag the change. Based on our review of current program materials, several categories have thinned considerably:
- ADHD generics — drugs like generic Adderall have largely exited discount lists, partly due to shortage-related supply volatility
- Certain GLP-1-adjacent medications — older diabetes generics remain, but newer agents were never added
- Some combination drugs — single-ingredient generics stay cheap; their two-in-one counterparts rarely do
The lesson: never assume. Verify against the current list before your refill date, because the version you print from a blog in 2022 is not the version in effect today.
Stacking the List With Other Savings
The most important thing to understand is that these programs are cash prices. They are not insurance claims, which means they do not touch your deductible — but they also mean you can decline to run the claim through your insurer entirely, a move that sometimes beats your copay outright.
Consider this stacking hierarchy:
- Check the discount list first. If your drug is on it at $4–$10, that may be your floor.
- Compare against discount card apps. Sometimes a negotiated card price undercuts even $4 lists on non-list drugs.
- Compare against your insurance copay. Run the numbers on all three before deciding which route to pay.
One caution: federal law prohibits using a manufacturer coupon alongside Medicare or Medicaid, and discount lists can interact oddly with accumulator programs. When in doubt, ask the pharmacy how a given payment method will be recorded.
The Bottom Line
The $4 list is not a relic — it is a functioning, if quiet, piece of the American drug pricing patchwork. But it rewards only the vigilant. Print the current list from each pharmacy's website, check it against your medications at every renewal, and treat it as one weapon among several. Two decades in, the cheapest thing about these programs is still what most people pay: nothing, because they never ask.
